Table 3. Adverse events during MKI treatment.
Any grade | G1-G2 (%) | G3-G4 (%) | |
---|---|---|---|
Hand-foot syndrome | 30 | 22 (50) | 8 (18.2) |
Diarrhea | 31 | 25 (56.8) | 6 (13.6) |
Fatigue | 31 | 29 (65.9) | 2 (4.6) |
Hypertension | 5 | 4 (9.0) | 1 (2.3) |
Alopecia | 11 | 9 (20.4) | 3 (6.8) |
Anorexia | 5 | 5 (11.3) | 0 |
Weight loss | 8 | 8 (18.2) | 0 |
Nausea | 9 | 8 (18.2) | 1 (2.3) |
Rash | 7 | 5 (11.3) | 2 (4.6) |
Hematologic toxicity | 1 | 1 (2.3) | 0 |
Pruritus | 1 | 1 (2.3) | 0 |
Secondary neoplasia | 1 | 0 | 1 (2.3) |
MKI: multikinase inhibitors.